AUGO Form 144: 22,367 Shares Proposed for Resale

AUGO filed a Form 144 reporting proposed sales of 22,367 common shares with an aggregate value of $1,459,835.47, dated 06/26/2026.

Rhea-AI Filing Summary

AUGO filed a Form 144 reporting proposed sales of 22,367 common shares with an aggregate value of $1,459,835.47, dated 06/26/2026. The filing also shows prior sales of 6,323 shares for $412,407.36 on 06/22/2026. Shares outstanding are listed as 83,789,223 as of 06/26/2026.

The notice lists the transaction method as a Form 144 resale on Nasdaq and references a stock option exercise dated 12/17/2024. The filing identifies the selling party and shows cash consideration where specified.

Insights

Corporate Governance / Insider Trading Analyst

Routine Form 144 notice: insider resale quantities and recent small prior sales recorded.

The filing lists a proposed resale of 22,367 common shares (aggregate $1,459,835.47) dated 06/26/2026, and prior dispositions of 6,323 shares for $412,407.36 on 06/22/2026. It also references a 12/17/2024 stock option exercise as the origin of the shares.

Transaction details show cash consideration and Nasdaq as the market; the filing does not state the distribution method beyond the Form 144 resale notice. Subsequent filings or market reports would show execution details and any remaining holdings.

Key Figures

Proposed shares to be sold: 22,367 shares Aggregate value of proposed resale: $1,459,835.47 Shares sold in prior 3 months: 6,323 shares +2 more

5 metrics

Proposed shares to be sold 22,367 shares Form 144 dated 06/26/2026

Aggregate value of proposed resale $1,459,835.47 Associated with 22,367 shares on 06/26/2026

Shares sold in prior 3 months 6,323 shares Sold on 06/22/2026 for $412,407.36 (Glauber Rosa Luvizotto)

Shares outstanding 83,789,223 shares Listed in securities table as of 06/26/2026

Stock option exercise date 12/17/2024 Referenced as origin of securities on the form

Key Terms

Form 144, stock option exercise, aggregate value

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"12/17/2024 | Stock option exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate value financial

"1459835.47 | 83789223 | 06/26/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AUGO's Form 144 report show?

It reports a proposed resale of 22,367 common shares with aggregate value $1,459,835.47 dated 06/26/2026. The filing also notes prior sales of 6,323 shares on 06/22/2026 for $412,407.36.

Who is listed as having sold shares recently in the AUGO filing?

The excerpt lists Glauber Rosa Luvizotto with sales of 6,323 common shares on 06/22/2026 for $412,407.36. The Form 144 also identifies the selling holder and contact details shown in the filing.

Are the shares tied to an option exercise in the AUGO filing?

Yes. The filing references a stock option exercise dated 12/17/2024 and lists cash as the consideration method for that exercise on the form's securities table.

How many AUGO shares were outstanding according to this excerpt?

The filing shows 83,789,223 shares outstanding06/26/2026 in the securities table included in the excerpt.

Will this Form 144 itself execute the sale of AUGO shares?

No. The Form 144 is a notification of proposed resale. It lists the proposed quantities and method (resale on Nasdaq) but does not confirm execution or settlement details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 05:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002120184
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aura Minerals Inc.
SEC File Number
Address of Issuer	3390 Mary Street Suite 116 Coconut Grove FLORIDA 33134
Phone	8668819982
Name of Person for Whose Account the Securities are To Be Sold	Glauber Rosa Luvizotto
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common shares	Merrill Lynch Pierce Fenner & Smith 19495 Biscayne Blvd. Suite 700 Aventura FL 33180	22367	1459835.47	83789223	06/26/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common shares	12/17/2024	Stock option exercise	Issuer			22367	12/17/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Glauber Rosa Luvizotto 3309 Mary Street - suite 116 Coconut Grove FL 33134	Common	06/22/2026	6323	412407.36

144: Remarks and Signature

Remarks
Date of Notice	06/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Glauber Rosa Luvizotto
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)